U.S.-Australia Rx “Transparency” Deal Applies To Medicare Part B
Executive Summary
Medicare Part B drug reimbursement decisions will be subject to the transparency provisions of the U.S.-Australia Free Trade Agreement, the U.S. Trade Representative says
You may also be interested in...
Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist
Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3
Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist
Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3
Rx Import Laws Would Not Be Blocked By Australia Trade Deal, USTR Says
The U.S.-Australia free trade agreement moving through Congress underscores the right of manufacturers to control resale of their products across national borders